B Fanget

701 total citations
16 papers, 546 citations indexed

About

B Fanget is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, B Fanget has authored 16 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in B Fanget's work include Viral Infections and Immunology Research (4 papers), Influenza Virus Research Studies (4 papers) and Virus-based gene therapy research (4 papers). B Fanget is often cited by papers focused on Viral Infections and Immunology Research (4 papers), Influenza Virus Research Studies (4 papers) and Virus-based gene therapy research (4 papers). B Fanget collaborates with scholars based in France, United States and Belgium. B Fanget's co-authors include B Montagnon, J. C. Vincent-Falquet, Robert G. Webster, Elena A. Govorkova, Irina V. Alymova, Shantha Kodihalli, Géraldine Grouard-Vogel, Olivier Dhellin, Pierre Vandepapelière and Xavier Mariette and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

B Fanget

16 papers receiving 512 citations

Peers

B Fanget

EPIDE

IMMUN

RHEUM

Phillip K. Weck United States

L H Hwang Taiwan

I. Gresser France

Clare Thompson United States

Jonas Söderholm Sweden

Weimin Tsai United States

Junji Fujita Japan

Sherry R. Crowe United States

Manfred Motz Germany

Bridget M. Donovan United States

Phillip K. Weck United States

B Fanget

319 ×1.6

EPIDE

297 ×1.8

IMMUN

162 ×1.0

61 ×0.4

46 ×0.4

RHEUM

Citations per year, relative to B Fanget B Fanget (= 1×) peers Phillip K. Weck

Countries citing papers authored by B Fanget

Since Specialization

Citations

This map shows the geographic impact of B Fanget's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Fanget with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Fanget more than expected).

Fields of papers citing papers by B Fanget

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Fanget. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Fanget. The network helps show where B Fanget may publish in the future.

Co-authorship network of co-authors of B Fanget

This figure shows the co-authorship network connecting the top 25 collaborators of B Fanget. A scholar is included among the top collaborators of B Fanget based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Fanget. B Fanget is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Durez, Patrick, Pierre Vandepapelière, Pedro C. Miranda, et al.. (2014). Therapeutic Vaccination with TNF-Kinoid in TNF Antagonist-Resistant Rheumatoid Arthritis: A Phase II Randomized, Controlled Clinical Trial. PLoS ONE. 9(12). e113465–e113465. 35 indexed citations

Lauwerys, Bernard, É. Hachulla, François Spertini, et al.. (2012). Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid. Arthritis & Rheumatism. 65(2). 447–456. 132 indexed citations

Vandepapelière, Pierre, Gerhard Rogler, Frederik C. Kruger, et al.. (2011). Safety, Immunogenicity and Clinical Phase I-II Results of TNFα-Kinoid Immunotherapeutic in Crohn's Disease Patients. Gastroenterology. 140(5). S–123. 13 indexed citations

Rogler, Gerhard, Pierre Michetti, Frederik C. Kruger, et al.. (2010). T1234 Active Therapeutic Immunization Against TNF With a TNF-Kinoid in Crohn's Disease Patients: A Phase 1-2 Study. Gastroenterology. 138(5). S–517. 6 indexed citations

Govorkova, Elena A., Mikhail Matrosovich, Alexander Tuzikov, et al.. (1999). Selection of Receptor-Binding Variants of Human Influenza A and B Viruses in Baby Hamster Kidney Cells. Virology. 262(1). 31–38. 46 indexed citations

Govorkova, Elena A., Shantha Kodihalli, Irina V. Alymova, B Fanget, & Robert G. Webster. (1999). Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.. PubMed. 98. 39–51; discussion 73. 67 indexed citations

Blondeau, Christine, et al.. (1998). Adjuvants for influenza vaccine. Research in Immunology. 149(1). 19–23. 21 indexed citations

Alymova, Irina V., Shantha Kodihalli, Elena A. Govorkova, et al.. (1998). Immunogenicity and Protective Efficacy in Mice of Influenza B Virus Vaccines Grown in Mammalian Cells or Embryonated Chicken Eggs. Journal of Virology. 72(5). 4472–4477. 35 indexed citations

Fanget, B, et al.. (1996). A varicella vaccine stable at 5 degrees C.. PubMed. 87. 167–71. 4 indexed citations

10.

Garín, Daniel, Emmanuel Vidor, Martine Wallon, et al.. (1995). Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults. Vaccine. 13(2). 220–224. 19 indexed citations

11.

Montagnon, B, B Fanget, & J. C. Vincent-Falquet. (1984). Industrial-Scale Production of Inactivated Poliovirus Vaccine Prepared by Culture of Vero Cells on Microcarrier. Clinical Infectious Diseases. 6(Supplement_2). S341–S344. 51 indexed citations

12.

Montagnon, B, J. C. Vincent-Falquet, & B Fanget. (1983). Thousand litre scale microcarrier culture of Vero cells for killed polio virus vaccine. Promising results.. PubMed. 55. 37–42. 40 indexed citations

13.

Montagnon, B, et al.. (1981). The large-scale cultivation of VERO cells in micro-carrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine.. PubMed. 47. 55–64. 65 indexed citations

14.

Montagnon, B, et al.. (1981). Comparison of sensitivity of VERO cell line versus primary monkey kidney cells in the detection of residual live polio virus during and after inactivation.. PubMed. 47. 151–5. 5 indexed citations

15.

Montagnon, B, et al.. (1980). Direct enzyme linked immunosorbent assay (ELISA) for quantification of poliomyelitis virus D-antigen.. PubMed. 46. 197–202. 5 indexed citations

16.

Montagnon, B, et al.. (1980). Contribution to the control of inactivated human influenza vaccines with the single radial diffusion method (SRD): Routine check, industrial super vision and vaccine standardisation. Comparative Immunology Microbiology and Infectious Diseases. 3(1-2). 207–218. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact